出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年4月
電気泳動市場 : 製品 [試薬 (タンパク質 & 核酸)、(ゲル電気泳動 (1D & 2D)、キャピラリー電気泳動 (CZE、CGE)、GDS、ソフトウェア]、用途 (研究、診断)、エンドユーザー (病院) & 地域別 – 2027年までの世界予測
Electrophoresis Market by Product (Reagents (Protein & Nucleic Acid), (Gel Electrophoresis (1D & 2D), Capillary Electrophoresis (CZE, CGE), GDS, Software), Application (Research, Diagnostics), End User (Hospitals) & Region – Global Forecast to 2028
| ページ数 | 282 |
| 図表数 | 303 |
| 種別 | 英文調査報告書 |
| 価格 |
The global electrophoresis market is projected to reach USD 4.1 Billion by 2028 from USD 3.1 Billion in 2023, at a CAGR of 5.7% during the forecast period. The growth of this market is majorly driven by the growth in the increasing incidence of cancer, infectious disease, and genetic disorders, and shift from plant-based to genome-based drug discovery.
However, time consuming operations and limited sample analysis to restrain the growth of electrophoresis market.
“The gel electrophoresis segment accounted for the highest market share in the electrophoresis systems market, by type, during the forecast period”
Based on the type of segment, the electrophoresis system market is categorized into gel electrophoresis systems, and capillary electrophoresis systems. The gel electrophoresis system is expected to witness a high market share during the forecast period. This can be attributed to factors such as the growing uptake of automated electrophoresis systems among researchers, academic institutions, and pharmaceutical & biotechnology companies.
“Vertical gel electrophoresis systems accounted for the highest CAGR during the forecast period”
Based on type, the gel electrophoresis systens market is segmented into horizontal gel electrophoresis systems and vertical gel electrophoresis systems. In 2022, the horizontal gel electrophoresis system dominated the market and vertical gel electrophoresis systems to observe the highest growth rate. Factors supporting the growth of vertical gel electrophoresis systems include accommodating larger sample sizes than horizontal instruments, owing to which they are increasingly used in analyzing large samples in protein studies.
“The North America segment accounted for the highest market share in the electrophoresis systems market, by region, during the forecast period”
Based on the region, the global electrophoresis market is categorized into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is expected to witness high market share during the forecast period. Stringent regulations for quality monitoring and process validation in the US pharmaceutical sector are also supporting the growth of the electrophoresis market.
Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (30%), Tier 2 (45%), and Tier 3 (25%)
• By Designation: C-level (20%), Director-level (20%), and Others (45%)
• By Region: North America (40%), Asia- Pacific (30%), Europe (20%), Latin America (7%) and Middle East & Africa(3%)
Prominent companies include Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. Inc. (US), QIAGEN N.V. (Netherlands), Lonza (Switzerland), Shimadzu Corporation (Japan), HOEFER INC.(US), Sebia Group (UK), Takara Bio Inc.(US), C.B.S. Scientific (US), 4Basebio PLC. (Germany), Helena Laboratories Corporation (US), Syngene (UK), VWR International (US), TBG Diagnostics Ltd. (Australia), Analytik Jena GMBH (Germany), Oprl Biosciences PVT.LTD. (India), Kaneka Eurogentec S.A. (Germany), Cleaver Scientific Ltd. (UK), Major Science Co., Ltd. (Taiwan), Bio World (India), National Analytical Corporation (India) and AES life sciences (Canada)
Research Coverage
This research report categorizes the electrophoresis market by product (electrophoresis reagents, electrophoresis systems, gel documentation systems and software), by application (research application, diagnostic applications, and quality control & process validation), by end user (academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers and other end users), and region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the electrophoresis market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the electrophoresis market. Competitive analysis of upcoming startups in the electrophoresis market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall electrophoresis market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (rising funding for proteomics and genomics research, growing industry-academia research collaborations, growing use of NGS and decliening cost of DNA sequencing, increasing number of clinical, forensic, and research labs, rising incidence of cancer, infectious diseases, and genetic disorders, and growing prominence of nanoproteomics), restraints (presence of alternative technologies offering better efficiency and results, and time-consuming operations and limited sample analysis), opportunities (high growth opportunities in developing countries, increasing demand for personalized medicines, and shift from plant-based to genome-based drug discovery), and challenges (safety concerns associated with electrophoresis reagents, and need for high procedural efficiency to ensure accurate results) influencing the growth of the electrophoresis market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the electrophoresis market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the electrophoresis market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the electrophoresis market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), among others in the electrophoresis market strategies.
目次
1 INTRODUCTION 36
1.1 STUDY OBJECTIVES 36
1.2 MARKET DEFINITION 36
1.2.1 INCLUSIONS AND EXCLUSIONS 37
1.2.2 MARKETS COVERED 37
FIGURE 1 ELECTROPHORESIS MARKET 37
1.2.3 GEOGRAPHIC SCOPE 38
1.2.4 YEARS CONSIDERED 38
1.3 CURRENCY CONSIDERED 39
1.4 STAKEHOLDERS 39
1.5 SUMMARY OF CHANGES 39
1.6 RESEARCH LIMITATIONS 40
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH APPROACH 41
FIGURE 2 RESEARCH DESIGN 41
2.1.1 SECONDARY RESEARCH 42
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY RESEARCH 43
FIGURE 3 PRIMARY SOURCES 43
2.1.2.1 Key data from primary sources 44
2.1.2.2 Key industry insights 45
2.1.2.3 Breakdown of primaries 45
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45
2.2 MARKET SIZE ESTIMATION 46
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 46
2.2.1 GROWTH FORECAST 47
FIGURE 6 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 47
FIGURE 7 TOP-DOWN APPROACH 48
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 49
FIGURE 8 DATA TRIANGULATION METHODOLOGY 49
2.4 MARKET SHARE ANALYSIS 50
2.5 STUDY ASSUMPTIONS 50
2.6 RISK ASSESSMENT 50
TABLE 1 RISK ASSESSMENT 50
2.7 IMPACT OF RECESSION: ELECTROPHORESIS MARKET 51
3 EXECUTIVE SUMMARY 52
FIGURE 9 ELECTROPHORESIS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 52
FIGURE 10 ELECTROPHORESIS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 53
FIGURE 11 ELECTROPHORESIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 53
FIGURE 12 GEOGRAPHIC ANALYSIS OF ELECTROPHORESIS MARKET 54
4 PREMIUM INSIGHTS 56
4.1 ELECTROPHORESIS MARKET OVERVIEW 56
FIGURE 13 INCREASING RESEARCH IN LIFE SCIENCES INDUSTRY TO DRIVE MARKET 56
4.2 EUROPE: CAPILLARY ELECTROPHORESIS SYSTEMS MARKET, BY TYPE 57
FIGURE 14 CAPILLARY ZONE ELECTROPHORESIS SEGMENT TO ACCOUNT FOR LARGEST SHARE OF EUROPEAN CAPILLARY ELECTROPHORESIS MARKET IN 2023 57
4.3 ELECTROPHORESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 58
FIGURE 15 CHINA TO WITNESS HIGHEST REVENUE GROWTH DURING FORECAST PERIOD 58
4.4 ELECTROPHORESIS MARKET, BY REGION (2023–2028) 58
FIGURE 16 NORTH AMERICA TO DOMINATE ELECTROPHORESIS MARKET TILL 2028 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
FIGURE 17 ELECTROPHORESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
5.2.1 DRIVERS 60
5.2.1.1 Rising funding for proteomics and genomics research 60
5.2.1.2 Growing industry-academia research collaborations 61
5.2.1.3 Growing use of NGS and declining cost of DNA sequencing 61
FIGURE 18 REDUCTION IN COST OF DNA SEQUENCING PER RAW MEGABASE, 2016–2021 (USD) 61
5.2.1.4 Increasing number of clinical, forensic, and research labs 62
5.2.1.5 Rising incidence of cancer, infectious diseases, and genetic disorders 62
TABLE 2 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (IN MILLION) 63
5.2.1.6 Growing prominence of nanoproteomics 63
5.2.2 RESTRAINTS 64
5.2.2.1 Presence of alternative technologies offering better efficiency and results 64
5.2.2.2 Time-consuming operations and limited sample analysis 64
5.2.3 OPPORTUNITIES 65
5.2.3.1 High growth opportunities in developing countries 65
5.2.3.2 Increasing demand for personalized medicines 65
FIGURE 19 PERSONALIZED MEDICINES ACCOUNTED FOR MORE THAN 25% OF FDA APPROVALS FOR LAST SEVEN YEARS 66
5.2.3.3 Shift from plant-based to genome-based drug discovery 66
5.2.4 CHALLENGES 67
5.2.4.1 Safety concerns associated with electrophoresis reagents 67
5.2.4.2 Need for high procedural efficiency to ensure accurate results 67
6 INDUSTRY INSIGHTS 68
6.1 INTRODUCTION 68
6.2 INDUSTRY TRENDS 68
6.2.1 INTEGRATION OF MICROFLUIDIC/LAB-ON-CHIP TECHNOLOGIES IN CAPILLARY ELECTROPHORESIS 68
6.2.2 NANOMATERIAL-BASED CAPILLARY ELECTROPHORESIS 69
6.2.3 TRANSITION FROM MANUAL ELECTROPHORESIS SYSTEMS TO AUTOMATED ELECTROPHORESIS SYSTEMS 70
6.3 PRICING ANALYSIS 71
TABLE 3 PRICE RANGE FOR ELECTROPHORESIS MARKET 71
6.4 CE-MS SYSTEMS 71
6.5 VALUE CHAIN ANALYSIS 72
FIGURE 20 ELECTROPHORESIS MARKET: VALUE CHAIN ANALYSIS 73
7 ELECTROPHORESIS MARKET, BY PRODUCT 74
7.1 INTRODUCTION 75
TABLE 4 ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 75
7.2 ELECTROPHORESIS REAGENTS 75
TABLE 5 ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 76
TABLE 6 ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION, 2021–2028 (USD MILLION) 76
7.2.1 PROTEIN ELECTROPHORESIS REAGENTS 77
7.2.1.1 Increased use of electrophoresis techniques for protein-based research to propel market 77
TABLE 7 PROTEIN ELECTROPHORESIS REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 78
7.2.2 NUCLEIC ACID ELECTROPHORESIS REAGENTS 78
7.2.2.1 Growing focus on DNA and RNA analyses to augment market 78
TABLE 8 NUCLEIC ACID ELECTROPHORESIS REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 79
7.3 ELECTROPHORESIS SYSTEMS 79
TABLE 9 ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 80
TABLE 10 ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY REGION, 2021–2028 (USD MILLION) 80
7.3.1 GEL ELECTROPHORESIS SYSTEMS 81
TABLE 11 GEL ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 82
7.3.1.1 Gel electrophoresis systems, by instrument type 82
TABLE 12 GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 82
7.3.1.2 Horizontal gel electrophoresis systems 83
7.3.1.2.1 Horizontal gel electrophoresis systems to account for larger market share during forecast period 83
TABLE 13 HORIZONTAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 83
7.3.1.3 Vertical gel electrophoresis systems 83
TABLE 14 VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 84
TABLE 15 VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 84
7.3.1.3.1 1D gel electrophoresis systems 85
7.3.1.3.1.1 High accuracy of 1D gel electrophoresis systems to drive demand 85
TABLE 16 1D GEL ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 86
7.3.1.3.2 2D gel electrophoresis systems 86
7.3.1.3.2.1 2D gel electrophoresis to provide best high-resolution profiling of low-abundance proteins 86
TABLE 17 2D GEL ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 87
7.3.1.4 Gel electrophoresis systems, by gel type 87
TABLE 18 GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 87
7.3.1.5 Polyacrylamide gel electrophoresis 87
7.3.1.5.1 Difficulty in preparation, handling, and detection of DNA to hinder market 87
TABLE 19 GEL CONCENTRATIONS FOR SIZE SEPARATION 88
TABLE 20 POLYACRYLAMIDE GEL ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 89
7.3.1.6 Agarose gel electrophoresis 89
7.3.1.6.1 Agarose gel electrophoresis to be widely used for separation of DNA and RNA samples 89
TABLE 21 AGAROSE GEL ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 90
7.3.2 CAPILLARY ELECTROPHORESIS SYSTEMS 90
TABLE 22 CAPILLARY ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 23 CAPILLARY ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 92
7.3.2.1 Capillary zone electrophoresis systems 92
7.3.2.1.1 Capillary zone electrophoresis systems to be adopted for identifying and verifying purity of human growth hormone 92
TABLE 24 CAPILLARY ZONE ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
7.3.2.2 Capillary gel electrophoresis systems 93
7.3.2.2.1 Capillary gel electrophoresis systems to separate large biological molecules based on their size 93
TABLE 25 CAPILLARY GEL ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 94
7.3.2.3 Capillary isoelectric focusing systems 94
7.3.2.3.1 Higher detectivity and lesser analysis time to result in high demand from pharmaceutical and biotechnology companies 94
TABLE 26 CAPILLARY ISOELECTRIC FOCUSING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 95
7.3.2.4 Micellar electrokinetic capillary chromatography systems 95
7.3.2.4.1 Micellar electrokinetic capillary chromatography systems to determine drugs with high protein content 95
TABLE 27 MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 96
7.3.2.5 Capillary isotachophoresis systems 96
7.3.2.5.1 Capillary isotachophoresis to be widely used in proteomic studies and preclinical research 96
TABLE 28 CAPILLARY ISOTACHOPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 97
7.3.2.6 Capillary electrochromatography systems 97
7.3.2.6.1 High efficiency, resolution, and selectivity of electrochromatography systems to aid market 97
TABLE 29 CAPILLARY ELECTROCHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 98
7.3.2.7 Other capillary electrophoresis systems 98
TABLE 30 OTHER CAPILLARY ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 99
7.4 GEL DOCUMENTATION SYSTEMS 99
7.4.1 GROWING CLINICAL RESEARCH INDUSTRY AND INCREASING USE OF MOLECULAR BIOLOGY TECHNIQUES IN PATHOLOGY LABORATORY PRACTICES TO PROPEL MARKET 99
TABLE 31 ELECTROPHORESIS MARKET FOR GEL DOCUMENTATION SYSTEMS, BY REGION, 2021–2028 (USD MILLION) 100
7.5 SOFTWARE 101
7.5.1 INCREASING USE OF SOFTWARE SOLUTIONS TO ANALYZE DATA AND DRAW CONCLUSIONS FROM ELECTROPHORESIS APPLICATIONS TO FUEL MARKET 101
TABLE 32 ELECTROPHORESIS MARKET FOR SOFTWARE, BY REGION, 2021–2028 (USD MILLION) 102
8 ELECTROPHORESIS MARKET, BY APPLICATION 103
8.1 INTRODUCTION 104
TABLE 33 ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
8.2 RESEARCH APPLICATIONS 104
8.2.1 TECHNOLOGICAL IMPROVEMENTS IN CAPILLARY ELECTROPHORESIS TO PROPEL MARKET 104
TABLE 34 ELECTROPHORESIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 106
8.3 DIAGNOSTIC APPLICATIONS 106
8.3.1 INCREASED USE OF CE MICROCHIP-BASED DIAGNOSTICS TO AID MARKET 106
TABLE 35 ELECTROPHORESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 108
8.4 QUALITY CONTROL & PROCESS VALIDATION 108
8.4.1 INCREASING FOCUS ON REGULATORY COMPLIANCE TO INCREASE ADOPTION OF ELECTROPHORETIC TECHNIQUES IN QUALITY CHECKS 108
TABLE 36 ELECTROPHORESIS MARKET FOR QUALITY CONTROL & PROCESS VALIDATION, BY REGION, 2021–2028 (USD MILLION) 109
9 ELECTROPHORESIS MARKET, BY END USER 110
9.1 INTRODUCTION 111
TABLE 37 ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 111
9.2 ACADEMIC & RESEARCH INSTITUTES 111
9.2.1 INCREASED FUNDING FOR RESEARCH TO RESULT IN HIGH ADOPTION OF ELECTROPHORESIS TECHNOLOGY 111
TABLE 38 ELECTROPHORESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 113
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 113
9.3.1 INCREASING FOCUS ON LAUNCHING QUALITY DRUGS TO SUPPORT MARKET 113
FIGURE 21 FDA APPROVALS FOR PERSONALIZED MEDICINES (2015–2021) 114
TABLE 39 ELECTROPHORESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 115
9.4 HOSPITALS & DIAGNOSTIC CENTERS 115
9.4.1 SERUM PROTEIN ELECTROPHORESIS IN HOSPITALS AND DIAGNOSTIC CENTERS TO HELP IDENTIFY DIFFERENT DISEASES 115
TABLE 40 ELECTROPHORESIS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION) 116
9.5 OTHER END USERS 116
TABLE 41 ELECTROPHORESIS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 117
10 ELECTROPHORESIS MARKET, BY REGION 118
10.1 INTRODUCTION 119
TABLE 42 ELECTROPHORESIS MARKET, BY REGION, 2021–2028 (USD MILLION) 119
10.2 NORTH AMERICA 119
FIGURE 22 NORTH AMERICA: ELECTROPHORESIS MARKET SNAPSHOT 120
10.2.1 NORTH AMERICA: IMPACT OF RECESSION 120
TABLE 43 NORTH AMERICA: ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 44 NORTH AMERICA: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 121
TABLE 45 NORTH AMERICA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 46 NORTH AMERICA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 47 NORTH AMERICA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 122
TABLE 48 NORTH AMERICA: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 49 NORTH AMERICA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 123
TABLE 50 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 51 NORTH AMERICA: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124
TABLE 52 NORTH AMERICA: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 124
10.2.2 US 124
10.2.2.1 US to dominate North American electrophoresis market during forecast period 124
TABLE 53 US: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 126
TABLE 54 US: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 55 US: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 56 US: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 127
TABLE 57 US: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 58 US: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 127
TABLE 59 US: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 60 US: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
TABLE 61 US: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 129
10.2.3 CANADA 129
10.2.3.1 Strong infrastructure and availability of funding for biomedical research to support market 129
TABLE 62 CANADA: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 63 CANADA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 64 CANADA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 65 CANADA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 131
TABLE 66 CANADA: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 67 CANADA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 132
TABLE 68 CANADA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 69 CANADA: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 133
TABLE 70 CANADA: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 133
10.3 EUROPE 133
10.3.1 EUROPE: IMPACT OF RECESSION 134
TABLE 71 EUROPE: ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 72 EUROPE: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 135
TABLE 73 EUROPE: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 74 EUROPE: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 75 EUROPE: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 136
TABLE 76 EUROPE: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 77 EUROPE: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 137
TABLE 78 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 79 EUROPE: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138
TABLE 80 EUROPE: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 139
10.3.2 GERMANY 139
10.3.2.1 Germany to hold largest share in European electrophoresis market during forecast period 139
TABLE 81 GERMANY: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 140
TABLE 82 GERMANY: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 83 GERMANY: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 84 GERMANY: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 141
TABLE 85 GERMANY: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 86 GERMANY: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 141
TABLE 87 GERMANY: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 88 GERMANY: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 89 GERMANY: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 143
10.3.3 FRANCE 143
10.3.3.1 Government of France to strongly support and invest in genomics and proteomics research 143
TABLE 90 FRANCE: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 144
TABLE 91 FRANCE: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 92 FRANCE: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 93 FRANCE: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 145
TABLE 94 FRANCE: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 95 FRANCE: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 145
TABLE 96 FRANCE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 97 FRANCE: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 146
TABLE 98 FRANCE: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 147
10.3.4 UK 147
10.3.4.1 Increasing awareness and research in personalized medicine to support market 147
TABLE 99 UK: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 148
TABLE 100 UK: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 101 UK: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 102 UK: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 149
TABLE 103 UK: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 104 UK: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 149
TABLE 105 UK: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 106 UK: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 107 UK: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 151
10.3.5 ITALY 151
10.3.5.1 Increasing life sciences R&D funding by government to drive market 151
TABLE 108 ITALY: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 152
TABLE 109 ITALY: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 110 ITALY: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 111 ITALY: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 153
TABLE 112 ITALY: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 113 ITALY: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 153
TABLE 114 ITALY: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 115 ITALY: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
TABLE 116 ITALY: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 155
10.3.6 SWITZERLAND 155
10.3.6.1 Well-established pharmaceutical & biotechnology industry to aid market 155
TABLE 117 SWITZERLAND: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 156
TABLE 118 SWITZERLAND: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 119 SWITZERLAND: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 120 SWITZERLAND: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 157
TABLE 121 SWITZERLAND: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 122 SWITZERLAND: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 158
TABLE 123 SWITZERLAND: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 124 SWITZERLAND: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 159
TABLE 125 SWITZERLAND: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 159
10.3.7 SPAIN 159
10.3.7.1 Well-established network of hospitals and research centers to increase initiatives for translational medicine research 159
TABLE 126 SPAIN: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 160
TABLE 127 SPAIN: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 128 SPAIN: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 129 SPAIN: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 161
TABLE 130 SPAIN: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 131 SPAIN: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 162
TABLE 132 SPAIN: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 133 SPAIN: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163
TABLE 134 SPAIN: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 163
10.3.8 REST OF EUROPE 163
TABLE 135 REST OF EUROPE: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 164
TABLE 136 REST OF EUROPE: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 137 REST OF EUROPE: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 138 REST OF EUROPE: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 165
TABLE 139 REST OF EUROPE: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 140 REST OF EUROPE: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 166
TABLE 141 REST OF EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 142 REST OF EUROPE: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167
TABLE 143 REST OF EUROPE: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 167
10.4 ASIA PACIFIC 167
FIGURE 23 ASIA PACIFIC: ELECTROPHORESIS MARKET SNAPSHOT 169
10.4.1 ASIA PACIFIC: IMPACT OF RECESSION 169
TABLE 144 ASIA PACIFIC: ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 145 ASIA PACIFIC: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 170
TABLE 146 ASIA PACIFIC: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 147 ASIA PACIFIC: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 148 ASIA PACIFIC: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 171
TABLE 149 ASIA PACIFIC: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 150 ASIA PACIFIC: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 172
TABLE 151 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 152 ASIA PACIFIC: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 153 ASIA PACIFIC: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 174
10.4.2 JAPAN 174
10.4.2.1 Initiatives toward development of precision medicine to support market 174
TABLE 154 JAPAN: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 175
TABLE 155 JAPAN: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 156 JAPAN: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 157 JAPAN: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 176
TABLE 158 JAPAN: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 159 JAPAN: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 177
TABLE 160 JAPAN: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 161 JAPAN: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178
TABLE 162 JAPAN: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 178
10.4.3 CHINA 178
10.4.3.1 Rising biopharmaceutical research to drive market 178
TABLE 163 CHINA: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 179
TABLE 164 CHINA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 165 CHINA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 166 CHINA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 180
TABLE 167 CHINA: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 168 CHINA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 181
TABLE 169 CHINA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 170 CHINA: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 171 CHINA: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 182
10.4.4 INDIA 182
10.4.4.1 Increasing pharma R&D and government funding in biotechnology sector to propel market 182
TABLE 172 INDIA: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 183
TABLE 173 INDIA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 174 INDIA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 175 INDIA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 184
TABLE 176 INDIA: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 177 INDIA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 185
TABLE 178 INDIA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 179 INDIA: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 186
TABLE 180 INDIA: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 186
10.4.5 AUSTRALIA 186
10.4.5.1 Increasing focus on precision medicine to fuel market 186
TABLE 181 AUSTRALIA: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 187
TABLE 182 AUSTRALIA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 183 AUSTRALIA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 184 AUSTRALIA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 188
TABLE 185 AUSTRALIA: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 186 AUSTRALIA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 189
TABLE 187 AUSTRALIA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 188 AUSTRALIA: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 190
TABLE 189 AUSTRALIA: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 190
10.4.6 REST OF ASIA PACIFIC 190
TABLE 190 REST OF ASIA PACIFIC: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 191
TABLE 191 REST OF ASIA PACIFIC: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 192 REST OF ASIA PACIFIC: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 193 REST OF ASIA PACIFIC: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 192
TABLE 194 REST OF ASIA PACIFIC: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 195 REST OF ASIA PACIFIC: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 193
TABLE 196 REST OF ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 197 REST OF ASIA PACIFIC: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 194
TABLE 198 REST OF ASIA PACIFIC: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 194
10.5 LATIN AMERICA 194
10.5.1 LATIN AMERICA: IMPACT OF RECESSION 195
TABLE 199 LATIN AMERICA: ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 200 LATIN AMERICA: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 196
TABLE 201 LATIN AMERICA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 202 LATIN AMERICA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 203 LATIN AMERICA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 197
TABLE 204 LATIN AMERICA: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 205 LATIN AMERICA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 197
TABLE 206 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 207 LATIN AMERICA: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 198
TABLE 208 LATIN AMERICA: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 199
10.5.2 BRAZIL 199
10.5.2.1 Growing genomics research and increasing pharmaceutical & biologics QC to drive market 199
TABLE 209 BRAZIL: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 199
TABLE 210 BRAZIL: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 211 BRAZIL: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 212 BRAZIL: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 200
TABLE 213 BRAZIL: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 214 BRAZIL: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 201
TABLE 215 BRAZIL: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 216 BRAZIL: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 202
TABLE 217 BRAZIL: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 203
10.5.3 MEXICO 203
10.5.3.1 Strong pharmaceutical industry to provide growth opportunities 203
TABLE 218 MEXICO: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 204
TABLE 219 MEXICO: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 220 MEXICO: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 221 MEXICO: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 205
TABLE 222 MEXICO: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 223 MEXICO: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 205
TABLE 224 MEXICO: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 225 MEXICO: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 206
TABLE 226 MEXICO: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 207
10.5.4 REST OF LATIN AMERICA 207
TABLE 227 REST OF LATIN AMERICA: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 207
TABLE 228 REST OF LATIN AMERICA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 229 REST OF LATIN AMERICA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 230 REST OF LATIN AMERICA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 208
TABLE 231 REST OF LATIN AMERICA: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 232 REST OF LATIN AMERICA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 209
TABLE 233 REST OF LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 234 REST OF LATIN AMERICA: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 210
TABLE 235 REST OF LATIN AMERICA: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 211
10.6 MIDDLE EAST & AFRICA 211
10.6.1 INCREASING R&D FUNDING BY PRIVATE SECTOR FOR BIOMARKER DISCOVERY TO SUPPORT MARKET 211
10.6.2 MIDDLE EAST & AFRICA: IMPACT OF RECESSION 212
TABLE 236 MIDDLE EAST & AFRICA: ELECTROPHORESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 212
TABLE 237 MIDDLE EAST & AFRICA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS REAGENTS, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 238 MIDDLE EAST & AFRICA: ELECTROPHORESIS MARKET FOR ELECTROPHORESIS SYSTEMS, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 239 MIDDLE EAST & AFRICA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY INSTRUMENT TYPE, 2021–2028 (USD MILLION) 213
TABLE 240 MIDDLE EAST & AFRICA: VERTICAL GEL ELECTROPHORESIS SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 241 MIDDLE EAST & AFRICA: GEL ELECTROPHORESIS SYSTEMS MARKET, BY GEL TYPE, 2021–2028 (USD MILLION) 214
TABLE 242 MIDDLE EAST & AFRICA: CAPILLARY ELECTROPHORESIS MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 243 MIDDLE EAST & AFRICA: ELECTROPHORESIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 215
TABLE 244 MIDDLE EAST & AFRICA: ELECTROPHORESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 216
11 COMPETITIVE LANDSCAPE 217
11.1 OVERVIEW 217
TABLE 245 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ELECTROPHORESIS MARKET 217
11.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 218
FIGURE 24 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ELECTROPHORESIS MARKET 218
11.3 MARKET SHARE ANALYSIS 218
TABLE 246 ELECTROPHORESIS MARKET: DEGREE OF COMPETITION 219
11.4 COMPETITIVE LEADERSHIP MAPPING 219
11.4.1 STARS 220
11.4.2 EMERGING LEADERS 220
11.4.3 PERVASIVE PLAYERS 220
11.4.4 PARTICIPANTS 220
FIGURE 25 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS: ELECTROPHORESIS MARKET 221
11.5 COMPANY EVALUATION QUADRANT FOR SMES/START-UPS 221
11.5.1 PROGRESSIVE COMPANIES 221
11.5.2 STARTING BLOCKS 222
11.5.3 RESPONSIVE COMPANIES 222
11.5.4 DYNAMIC COMPANIES 222
FIGURE 26 COMPANY EVALUATION MATRIX FOR SMES/START-UPS: ELECTROPHORESIS MARKET 223
11.6 COMPANY FOOTPRINT ANALYSIS 224
TABLE 247 OVERALL COMPANY FOOTPRINT 224
TABLE 248 COMPANY REGIONAL FOOTPRINT 225
TABLE 249 COMPANY PRODUCT FOOTPRINT 226
11.7 COMPETITIVE SCENARIO 227
11.7.1 KEY PRODUCT LAUNCHES 227
TABLE 250 KEY PRODUCT LAUNCHES 227
11.7.2 KEY DEALS 227
TABLE 251 KEY DEALS 227
11.7.3 OTHER KEY DEVELOPMENTS 228
TABLE 252 OTHER KEY DEVELOPMENTS 228
12 COMPANY PROFILES 229
12.1 KEY PLAYERS 229
(Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View)*
12.1.1 BIO-RAD LABORATORIES, INC. 229
TABLE 253 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 229
FIGURE 27 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 230
12.1.2 THERMO FISHER SCIENTIFIC INC. 233
TABLE 254 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 233
FIGURE 28 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 234
12.1.3 DANAHER CORPORATION 237
TABLE 255 DANAHER CORPORATION: COMPANY OVERVIEW 237
FIGURE 29 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 238
12.1.4 AGILENT TECHNOLOGIES, INC. 241
TABLE 256 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 241
FIGURE 30 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 242
12.1.5 MERCK KGAA 246
TABLE 257 MERCK KGAA: COMPANY OVERVIEW 246
FIGURE 31 MERCK KGAA: COMPANY SNAPSHOT (2022) 247
12.1.6 PERKINELMER, INC. 249
TABLE 258 PERKINELMER, INC.: COMPANY OVERVIEW 249
FIGURE 32 PERKINELMER, INC.: COMPANY SNAPSHOT (2022) 250
12.1.7 QIAGEN N.V. 251
TABLE 259 QIAGEN N.V.: COMPANY OVERVIEW 251
FIGURE 33 QIAGEN N.V.: COMPANY SNAPSHOT (2022) 252
12.1.8 LONZA 254
TABLE 260 LONZA: COMPANY OVERVIEW 254
FIGURE 34 LONZA: COMPANY SNAPSHOT (2022) 255
12.1.9 SHIMADZU CORPORATION 257
TABLE 261 SHIMADZU CORPORATION: COMPANY OVERVIEW 257
FIGURE 35 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2022) 258
12.1.10 HOEFER INC. 259
TABLE 262 HOEFER INC.: COMPANY OVERVIEW 259
12.1.11 SEBIA 260
TABLE 263 SEBIA: COMPANY OVERVIEW 260
12.1.12 TAKARA BIO INC. 262
TABLE 264 TAKARA BIO INC.: COMPANY OVERVIEW 262
FIGURE 36 TAKARA BIO INC.: COMPANY SNAPSHOT (2022) 263
12.1.13 C.B.S. SCIENTIFIC 265
TABLE 265 4BASEBIO: COMPANY OVERVIEW 265
FIGURE 37 4BASEBIO: COMPANY SNAPSHOT (2021) 266
12.1.14 HELENA LABORATORIES CORPORATION 268
TABLE 266 HELENA LABORATORIES CORPORATION: COMPANY OVERVIEW 268
12.2 OTHER PLAYERS 269
12.2.1 SYNGENE 269
12.2.2 VWR INTERNATIONAL, LLC (AVANTOR) 271
12.2.3 TBG DIAGNOSTICS LIMITED 272
12.2.4 ANALYTIK JENA GMBH 273
12.2.5 OPRL BIOSCIENCES PVT., LTD. 274
12.2.6 KANEKA EUROGENTEC S.A. 275
12.2.7 CLEAVER SCIENTIFIC LTD. 276
12.2.8 MAJOR SCIENCE CO., LTD. 277
12.2.9 BIO WORLD 279
12.2.10 NATIONAL ANALYTICAL CORPORATION 280
12.2.11 AES LIFE SCIENCES 281
*Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX 282
13.1 DISCUSSION GUIDE 282
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 288
13.3 CUSTOMIZATION OPTIONS 290
13.4 RELATED REPORTS 290
13.5 AUTHOR DETAILS 292